Top 10 Gas Utility Companies To Watch For 2015

Check out Jim Cramer's latest trading recommendations on "Action Alerts Plus". (Updates from 10:46 a.m. ET with closing information.)

NEW YORK (TheStreet) -- Here's what Jim Cramer had to say on CNBC's "Squawk on the Street" Thursday.

Core Laboratories (CLB) may have found the country's largest oil field, Cramer said. If so, Pioneer Natural Resources (PXD) will be the main beneficiary. CLB jumped 8.5% to $189.85.

PPG Industries (PPG) "has fabulous margins" and CEO Charles Bunch continues to deliver, Cramer said. PPG was up 5% to $174.47. Cramer was "thrilled" Nucor (NUE) was finally able to beat earnings estimates after missing for so many quarters. NUE rose 2% to $50.79. Alkermes (ALKS) has a few anti-opiate drugs and Cramer believes in the company and CEO Richard Pops. ALKS vaulted 8.5% to $35.38. Cramer said he was looking for technology companies and found that many investors were piling into 3D Systems (DDD) and other 3-D printing stocks. DDD was 2.7% higher at $56.76. Morgan Stanley downgraded Clorox (CLX) to sell, based on valuation. Cramer agreed, but also argued that the company has a 3.3% dividend yield and great management. CLX fell nearly 1% to $85.25. To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here. -- Written by Bret Kenwell in Petoskey, Mich. Follow @BretKenwell

Top 10 Gas Utility Companies To Watch For 2015: iShares S&P Small-Cap 600 Value ETF (IJS)

The iShares S&P SmallCap 600 Value Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Standard & Poor�� SmallCap 600/Citigroup Value Index (the Index). The Index measures the performance of the small-capitalization value sector of the United States equity market. The Index is a subset of the S&P SmallCap 600 Index and consists of those companies exhibiting the strongest value characteristics within the S&P SmallCap 600 Index.

The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Barclays Global Fund Advisors (BGFA) acts as the investment advisor of the Fund.

Advisors' Opinion:

• [By Gary Gordon]

  On behalf of most of my clients in 2013, I chose to overweight tech and health care. However, I did so with areas that are traditionally less volatile. I continue to own Powershares Pharmaceuticals (PJP) and/or SPDR Select Healthcare (XLV). I’ve been a proponent of “old tech” with the attractive prices and dividends; First Trust NASDAQ Tech Dividend (TDIV) fits the bill. Additionally, I have remained faithful to iShares Small Cap Value (IJS) for small-cap exposure, rather than hop on the IWO express.

Top 10 Gas Utility Companies To Watch For 2015: Pennsylvania Real Estate Investment Trust (PEI)

Pennsylvania Real Estate Investment Trust (PREIT), incorporated on September 29, 1997, is a fully integrated, self-managed and self-administered real estate investment trust (REIT). The Company has a primary investment focus on retail shopping malls located in the eastern half of the United States, primarily in the Mid-Atlantic region. As of December 31, 2012, the Company owned interests in 46 retail properties, of which 42 were operating properties, three were development properties and one was classified as held for sale. The 42 operating properties, which are classified in continuing operations, include 36 enclosed malls and six strip and power centers, have a total of 30.7 million square feet and operate in 12 states. The Company and partnerships in which the Company owns an interest owned 23.9 million square feet at these properties (excluding space owned by anchors). The development portion of the Company's portfolio contains three properties in two states, with two classified as mixed use (a combination of retail and other uses) and one classified as other. In January 2013, the Company sold its interests in Paxton Towne Centre in Harrisburg, Pennsylvania and Phillipsburg Mall in Phillipsburg, New Jersey. In February 2013, the Company sold Orlando Fashion Square in Orlando, Florida. In November 2013, the Company sold Chambersburg Mall in Chambersburg, PA.

As of December 31, 2012, the Company had four properties, which were classified as held for sale, two of which were malls and two of which were power centers. The Company is engaged in the ownership, management, leasing, acquisition, redevelopment and development of enclosed malls. The Company's malls include national or regional department stores, large format retailers or other anchors and a diverse mix of national, regional and local in-line stores offering apparel (women's, family, teen, children's, men's), shoes, eyewear, cards and gifts, jewelry, sporting goods, home furnishings, drug stores, electronics and books/music/movi! es, among other things. Its malls have restaurants and/or food courts, and some of the malls have multi-screen movie theaters and other entertainment options, either as part of the mall or on outparcels around the perimeter of the mall property. In addition, its malls have outparcels containing restaurants, banks or other stores. It derives its revenue from rent received under leases with tenants for space at retail properties in its real estate portfolio.

Advisors' Opinion:

• [By Rich Duprey]

  Pennsylvania Real Estate Investment Trust� (NYSE: PEI  ) �reported first-quarter results yesterday that were below consensus expectations on the top line but came in ahead on the bottom line, causing the company to�raise guidance�for the full year.

• [By Marc Bastow]

  Retail shopping mall real estate investment trust Pennsylvania REIT (PEI) raised its quarterly dividend 11% to 20 cents per share, payable on Dec. 16 to shareholders of record as of Dec. 2.
  PEI Dividend Yield: 4.74%
  

Best Supermarket Stocks To Own For 2015: Six Flags Entertainment Corporation New(SIX)

Six Flags Entertainment Corporation owns and operates regional theme, water, and zoological parks. The company?s parks offers various selection of state-of-the-art and traditional thrill rides, water attractions, themed areas, concerts and shows, restaurants, game venues, and retail outlets. It owns and operates 19 parks, including 17 parks in the United States; 1 park in Mexico City, Mexico; and 1 park in Montreal, Canada. The company was formerly known as Six Flags, Inc. and changed its name to Six Flags Entertainment Corporation in April 2010. Six Flags Entertainment Corporation was founded in 1971 and is based in Grand Prairie, Texas.

Advisors' Opinion:

• [By Bryan Murphy]

  It's been a while since investors have heard anything from Independent Film Development Corporation (OTCMKTS:IFLM), but like many of the horror films the company is now aiming to recreate in theme park form, the market can expect news and announcements from IFLM when it least expects it. And, though this morning's news from IndyFilmCorp wasn't exactly earth-shattering, it does push the organization one step closer to taking on - and even beating - the likes of The Walt Disney Company (NYSE:DIS) and Six Flags Entertainment Corp. (NYSE:SIX) at their own game... theme parks.

• [By Seth Jayson]

  Six Flags Entertainment (NYSE: SIX  ) reported earnings on July 22. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended June 30 (Q2), Six Flags Entertainment missed slightly on revenues and missed estimates on earnings per share.

• [By Rick Aristotle Munarriz]

  Alamy Sometime, companies can make brilliant moves; other times, things don't work out quite as planned. From an airline overpaying its departing CEO to a new way to eat a waffle in the morning, here's a rundown of this week's best and worst results from the business world. Cedar Fair (FUN) -- Winner There were plenty of reasons to expect amusement park operator Cedar Fair to post lower revenue than it did a year earlier. The crowd-drawing Easter holiday slipped into the first quarter this year. Cedar Fair sold ones of its parks. There was one week less in the second quarter than during last year's period. More importantly, rival Six Flags (SIX) posted a 3 percent decline in revenue during the same period a few days ago. However, the parent company of Cedar Point and Knott's Berry Farm came through with a 1 percent uptick in revenue as guest spending was more than enough to offset the slowing turnstile clicks. This may be a small step, but it's welcome at a time when it faced the same fierce headwinds that many of its coaster rides do. J.C. Penney (JCP) -- Loser Activist investor Bill Ackman is raising a stink at J.C. Penney. Has he forgotten what happened the last time? Ackman is frustrated that the chain has stuck to former CEO Mike Ullman as its interim helmsman for too long. He wants the stumbling retailer to rush the process and bring another former J.C. Penney CEO to step in as chairman of the board. The problem here is that it was Ackman that pushed for J.C. Penney to bring on Apple Store mastermind Ron Johnson to rescue the chain two years ago. The makeover went terribly, and sales fell sharply as Johnson's moves alienated loyal shoppers without wooing new customers. Ackman is an accomplished investor, but it's hard to take him seriously here. Yum! Brands (YUM) -- Winner The parent company behind Taco Bell, KFC, and Pizza Hut made the cut in this weekly column last week after introducing a fast casual concept called KFC eleven that upgrades the me

• [By John Udovich]

  While�most investors probably overlook the theme park sector, theme park stocks like SeaWorld Entertainment Inc (NYSE: SEAS), Six Flags Entertainment Corp (NYSE: SIX), Cedar Fair, L.P. (NYSE: FUN) and Independent Film Development Corporation (OTCMKTS: IFLM) have been producing returns ranging from being down 10.3% to up as much as 207.5% since the start of the year. Moreover, theme park stocks will remain active as consider the following news coming from important theme park stocks:

Top 10 Gas Utility Companies To Watch For 2015: Regency Energy Partners LP (RGP)

Regency Energy Partners LP (the Partnership), incorporated on September 8, 2005, is engaged in the gathering and processing, contract compression, treating and transportation of natural gas and the transportation, fractionation and storage of natural gas liquids (NGLs). The Partnership operates in five business segments: Gathering and Processing, Joint Ventures, Contract Compression, Contract Treating, and Corporate and Others. Its assets are primarily located in Texas, Louisiana, Arkansas, Pennsylvania, California, Mississippi, Alabama, West Virginia and the mid-continent region of the United States, which includes Kansas, Colorado and Oklahoma. In May 2013, Regency Energy Partners LP closed the acquisition of Southern Union Gathering Company, LLC from Southern Union Company. In February 2014, Regency Energy Partners LP closed its acquisition of the midstream business of Hoover Energy Partners LP.

During the year ended December 31, 2012, Lone Star NGL LLC (Lone Star), a newly formed joint venture that is owned 70% by Energy Transfer Partners, L.P. (ETP) and 30% by the Partnership, acquired all of the membership interest in LDH Energy Asset Holdings LLC (LDH), a wholly owned subsidiary of Louis Dreyfus Highbridge Energy LLC. The Partnership focuses on providing midstream services in some of the most prolific natural gas producing regions in the United States, including the Eagle Ford, Haynesville, Barnett, Fayetteville, Marcellus, Bone Spring, and Avalon shales as well as the Permian Delaware basin and the mid-continent region. The Partnership provides wellhead-to-market services to producers of natural gas, which include transporting raw natural gas from the wellhead through gathering systems, processing raw natural gas to separate NGLs and selling or delivering the pipeline natural gas and NGLs to various markets and pipeline systems.

The Partnership owns and operates a fleet of compressors used to provide turn-key natural gas compression services for customer specific syst! ems. The Partnership owns and operates a fleet of equipment used to provide treating services, such as carbon dioxide and hydrogen sulfide removal, natural gas cooling, dehydration and BTU management, to natural gas producers and midstream pipeline companies.

Gathering and Processing Operations

The Partnership operates gathering and processing assets in four geographic regions of the United States: north Louisiana, the mid-continent region of the United States, south Texas and west Texas. The Partnership�� north Louisiana assets gather, compress, treat and dehydrate natural gas in five Parishes (Claiborne, Union, DeSoto, Lincoln and Ouachita) of north Louisiana and Shelby County, Texas. Its assets also include two cryogenic natural gas processing facilities, a refrigeration plant located in Bossier Parish, a conditioning plant located in Webster Parish, an amine treating plant in DeSoto Parish, and an amine treating plant in Lincoln Parish. The Partnership�� south Texas assets gather, compress, treat and dehydrate natural gas in LaSalle, Webb, Karnes, Atascosa, McMullen, Frio and Dimmitt counties. The pipeline systems that gather this gas are connected to third-party processing plants and its treating facilities that include an acid gas reinjection well located in McMullen County, Texas.

One of the Partnership�� treating plants consists of inlet gas compression, a 60 one million cubic feet per day amine treating unit, a 55 one million cubic feet per day amine treating unit and a 40 ton (per day) liquid sulfur recovery unit. In January 2012, it completed an expansion of the treating plant, adding an incremental 20 one million cubic feet per day of treating capacity to the facility. The Partnership owns a 60% interest in ELG that includes a treating plant in Atascosa County with a 500 gallons per minute amine treater, pipeline interconnect facilities and approximately 13 miles of ten inch diameter pipeline. Talisman Energy USA Inc. and Statoil Texas Onshore Pro! perties L! P own the remaining 40% interest. It operates this plant and the pipeline for the joint venture while its joint venture partner operates a lean gas gathering system in the Edwards Lime natural gas trend that delivers to this system.

The Partnership�� west Texas gathering system assets offer wellhead-to-market services to producers in Ward, Winkler, Reeves, and Pecos counties, which surround the Waha Hub. The NGL market outlets include Lone Star's west Texas NGL pipeline. It offers producers four different levels of natural gas compression on the Waha gathering system. The Waha processing plant is a cryogenic natural gas processing plant that processes raw natural gas gathered in the Waha gathering system. The Waha processing plant also includes an amine treating facility, which removes carbon dioxide and hydrogen sulfide from raw natural gas gathered before moving the natural gas to the processing plant.

The Partnership�� mid-continent region includes natural gas gathering systems located primarily in Kansas and Oklahoma. Its mid-continent gathering assets are extensive systems that gather, compress and dehydrate low-pressure gas from approximately 1,500 wells. These systems are geographically concentrated, with each central facility located within 90 miles of the others. The Partnership also owns the Hugoton gathering system that has approximately 1,875 miles of pipeline extending over nine counties in Kansas and Oklahoma. This system is operated by a third party. Its mid-continent systems are located in two natural gas producing regions in the United States, the Hugoton Basin in southwest Kansas and the Anadarko Basin in western Oklahoma.

Joint Ventures Operations

The Partnership owns investments in four joint ventures: a 49.99% general partner interest in RIGS Haynesville Partnership Co., a general partnership, and its wholly-owned subsidiary, Regency Intrastate Gas LP (HPC); a 50% membership interest in MEP; a 30% membership interest in Lone St! ar, and a! 33.33% membership interest in Ranch JV. HPC owns RIGS, a 450-mile intrastate pipeline that delivers natural gas from northwest Louisiana to downstream pipelines and markets. MEP owns an interstate natural gas pipeline with approximately 500 miles stretching from southeast Oklahoma through northeast Texas, northern Louisiana and central Mississippi to an interconnect with the Transcontinental Gas Pipe Line system in Butler, Alabama. Lone Star is an entity owning a diverse set of midstream energy assets, including NGL pipelines, storage, fractionation and processing facilities located in the states of Texas, Mississippi and Louisiana.

Contract Compression Operations

The natural gas contract compression segment services include designing, sourcing, owning, installing, operating, servicing, repairing and maintaining compressors and related equipment. These field-wide applications include compression for natural gas gathering and natural gas processing. The Partnership�� contract compression operations are primarily located in Texas, Louisiana, Arkansas, Pennsylvania and California.

Contract Treating Operations

The Partnership owns and operates a fleet of equipment used to provide treating services, such as carbon dioxide and hydrogen sulfide removal, natural gas cooling, dehydration and BTU management, to natural gas producers and midstream pipeline companies. Its contract treating operations are primarily located in Texas, Louisiana and Arkansas.

The Company competes with PELICO Pipeline, LLC (Pelico), ETP, KMP, Chesapeake Midstream Partners, L.P., Enterprise Products Partners LP, DCP Midstream Partners, L.P., Copano Energy, L.L.C, Southern Union Gas Services, Targa Resources Partners L.P., ONEOK Partners L.P., Penn Virginia Resource Partners, L.P., CenterPoint Energy Transmission, Gulf South Pipeline, L.P., Texas Gas Transmission, LLC, Gulf Crossing Pipeline, Centerpoint Energy Gas Transmission and Natural Gas Pipeline Co. of America, Ext! erran Hol! dings, Inc., Compressor Systems, Inc., USA Compression, Valerus Compression Services LP, J-W Energy Company, TransTex Gas Services, LP, Cardinal Midstream LLC, SouthTex Treaters, Interstate Treating Inc., Thomas Russell Co. and Spartan Energy Group.

Advisors' Opinion:

• [By Lauren Pollock]

  Regency Energy Partners L.P(RGP). agreed to acquire PVR Partners for about $3.8 billion, creating a significant gas-gathering and processing company focused on unconventional energy plays across the U.S. Regency said its offer is valued at $28.68 per PVR unit, a 26% premium over Wednesday’s close. The units�surged 18% to $27 premarket.

Top 10 Gas Utility Companies To Watch For 2015: Sodexo SA (SW)

Sodexo SA, (formerly Sodexho Alliance SA), is a global provider of services in three primary business areas: The On-site Services Solutions offer various services that range from food services to construction management, reception to the maintenance of scanners and laboratory equipment, management of data centers, leisure cruises and provides housekeeping to rehabilitation services at correctional facilities. The Motivation Solutions division provides passes and vouchers, comprising Restaurant Pass, Gift Pass, Sport Pass, Training Voucher, Service Card and Book Card, among others. The Company also provides Personal and Home Services in the form of childcare, tutoring, concierge services and in-home service care facilities. The Company is present in 80 countries in a number of geographic areas, such as North America, South America, Continental Europe and United Kingdom and Ireland. Advisors' Opinion:

• [By Glenwoods]

  Recently giant food conglomerate, Cargill announced it had partnered with the Swiss biosynthetic pharmaceutical company, Evolva (EVE:SW), to develop a more consistent and less expensive stevia sweetener via Evolva�� microbial fermentation-based process.� This is big news for the future of stevia because a microbial fermentation-based process does not have to rely on soil conditions or weather, and stevia can be manufactured anywhere, thus having the potential of guaranteeing an endless supply line of stevia.� Through the microbial fermentation, the manufacturer has the capability to process the key sweet individual components of stevia using low-cost plant sugars, and allows for the individual components of stevia, regardless of how minute, to be developed creating blends in any volume, which then could open the door for these manufacturers to fine-tune its stevia to local tastes.� But what would be most attractive is that, because the fermentation process does not require the entire plant, the method could conceivably shave upwards of 70% off the cost of producing stevia extracts.�

Top 10 Gas Utility Companies To Watch For 2015: Otter Tail Corporation(OTTR)

Otter Tail Corporation engages in electric and nonelectric operations in the United States and internationally. It operates in six segments: Electric, Plastics, Manufacturing, Health Services, Food Ingredient Processing, and Other Business Operations. The Electric segment includes the production, transmission, distribution, and sale of electric energy through coal, wind, hydro, natural gas, and oil in Minnesota, North Dakota, and South Dakota. As of December 31, 2009, it provided electricity to approximately 130,900 customers, including residential, industrial, commercial, and other customers. This segment also operates as a wholesale participant in the Midwest Independent Transmission System Operator markets. The Plastics segment involves in producing polyvinyl chloride (PVC) pipes. The Manufacturing segment engages in the production of wind towers; contract machining; metal parts stamping and fabrication; production of waterfront equipment; and material and handling tray s, and horticultural containers. The Health Services segment sells diagnostic medical equipment, patient monitoring equipment, and related supplies and accessories. This segment also provides equipment maintenance service and diagnostic imaging services; and involves in the rental of diagnostic medical imaging equipment to various medical institutions. The Food Ingredient Processing segment produces dehydrated potato products. The Other Business Operations segment engages in residential, commercial, and industrial electric contracting; fiber optic and electric distribution systems; water, wastewater, and HVAC systems construction; and transportation and energy services businesses. The company was formerly known as Otter Tail Holding Company and changed its name to Otter Tail Corporation in 2001. Otter Tail Corporation was founded in 1907 and is based in Fergus Falls, Minnesota.

Advisors' Opinion:

• [By Dividend]

  Otter Tail (OTTR) has a market capitalization of $1.13 billion. The company employs 2,286 people, generates revenue of $859.24 million and has a net income of $38.97 million. Otter Tail�� earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $142.22 million. The EBITDA margin is 16.55 percent (the operating margin is 8.02 percent and the net profit margin 4.54 percent).

• [By Marc Bastow]

  Electric utility holding company Otter Tail (OTTR) raised its quarterly dividend 1.6% to 30.25 cents per share, payable on Mar. 10 to shareholders of record as of Feb. 14.
  OTTR Dividend Yield: 4.47%

• [By Richard Stavros]

  In examining the top two stock sellers and top two stock buyers listed above, we illustrate how these companies are managing their efforts to return cash to shareholders (See Chart C). The chart clearly shows that those firms that were making stock buybacks had better shareholder yields than those that were making stock issuances, namely Otter Tail Corp (NYSE: OTTR) and The AES Corp (NYSE: AES).

Top 10 Gas Utility Companies To Watch For 2015: Orthofix International N.V.(OFIX)

Orthofix International N.V., a medical device company, designs, develops, manufactures, markets, and distributes medical equipment used principally by musculoskeletal medical specialists for orthopedic applications. The company offers spinal implant products, and related human cellular and tissue based products used in surgical procedures; non-invasive regenerative stimulation products for use in bone growth and spinal fusions, and to treat non-union fractures; external and internal fixation devices for use in fracture repair, limb lengthening, and bone reconstruction; and bracing products for use in ligament injury prevention, pain management, and protection of surgical repair. Its products also include a device for cold therapy and bone cement, as well as devices for the removal of bone cement used to fix artificial implants. The company provides its products for the spine, orthopedics, and sports medicine market sectors serving independent third parties, including hospi tals, doctors, healthcare providers, and third-party payors, as well as patients. It distributes its products in the United States, the United Kingdom, Italy, Germany, Switzerland, Austria, France, Belgium, Brazil, and Puerto Rico through direct sales representatives and independent distributors. Orthofix International N.V. was founded in 1979 and is headquartered in Curacao, the Netherlands Antilles.

Advisors' Opinion:

• [By Sean Williams]

  What: Shares of Orthofix International (NASDAQ: OFIX  ) , a medical device company specializing in spinal and orthopedic applications, shed as much as 21% of their value after the company reported its first-quarter results and received four analyst downgrades.

Top 10 Gas Utility Companies To Watch For 2015: BioCryst Pharmaceuticals Inc.(BCRX)

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer to develop new therapeutic candidates. The company has three novel late-stage compounds in development, which include Peramivir, a neuraminidase inhibitor for the potential treatment of influenza; BCX4208, a purine nucleoside phosphorylase (PNP) inhibitor for gout; and Forodesine, a PNP inhibitor for cutaneous T-cell lymphoma (CTCL) and chronic lymphocytic leukemia (CLL). Peramivir is being developed under a contract from the Biomedical Advanced Research and Development Authority within the United States Department of Health and Human Services. Forodesine has been granted orphan drug status by the FDA for thr ee indications, which include T-cell non-Hodgkin?s lymphoma, including CTCL; CLL and related leukemias, including T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for treatment of B-ALL. The FDA has also granted fast track status to the development of forodesine for the treatment of relapsed or refractory T-cell leukemia, and special protocol assessment from the FDA for forodesine to conduct a pivotal clinical trial in CTCL with an oral formulation. The company announced the initiation of a Phase 2b study of BCX4208 as add-on therapy in gout patients who have not responded to allopurinol therapy alone. BioCryst Pharmaceuticals utilizes crystallography and structure-based drug design to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. The company was founded in 1986 and is headquartered in Durham, North Carolina.

Advisors' Opinion:

• [By Monica Gerson]

  BioCryst Pharmaceuticals (NASDAQ: BCRX) shares gained 5.98% to $6.91 in the pre-market session after the company has been awarded contract by the National Institute of Allergy and Infectious Diseases to develop BCX4430 for the treatment of Marburg virus disease.

• [By Sean Williams]

  Perhaps no shareholders jumped for more joy over the past week than those of BioCryst Pharmaceuticals (NASDAQ: BCRX  ) , whose shares shot up 88% this week on word of a positive early-stage clinical trial for BCX4161. In a different context, shares have now jumped 155% in just the past two weeks. The oral experimental drug, BCX4161, which is designed to treat a rare condition known as hereditary angioedema (HAE), was considered safe and well tolerated among patients, and the company anticipates moving on to mid-stage testing soon. However, as the Fools Brian Orelli was quick to point out, this data came from a subset of healthy volunteers, and there's little guarantee it will translate into success in future trials on patients that do suffer from HAE.

• [By John Udovich]

  While the Twitter IPO has been grabing everyone�� attention, biotech IPOs continue to dominate both biotech and IPO news with Karyopharm Therapeutics Inc (NASDAQ: KPTI) going public yesterday and�Relypsa (NASDAQ: RLYP), TetraLogic Pharmaceuticals (NASDAQ: TLOG), Vital Therapies (NASDAQ: VTL) and Xencor (NASDAQ: XNCR) filing to go public in the near future�(despite the sector producing some�ugly charts�for the month of October) plus�another small cap called TNI BioTech (OTCMKTS: TNIB) has also been producing a steady flow of news:

  Karyopharm Therapeutics Debuts. Yesterday, small cap Karyopharm Therapeutics, which is working on a drug that aids the body�� natural tumor-suppressing proteins,�debuted at the top of�its range to raise $109 million in an upsized�offering of 6.8 million shares at $16 apiece with shares closing at $16.81. It should be noted that Karyopharm Therapeutics��lead drug candidate (Selinexor) is in early-stage clinical trials�and the company lost�lost nearly $12.5 million on revenue of $366,000 during the first six months of this year. Biotech IPOs by Region. On an interesting note, Luke Timmerman, the National Biotech Editor of Xconomy, has written a�good�article tracking biotech or life sciences IPOs by region. By his count, Boston is home to eight of the 45 (18%) of the life sciences IPOs this year (its companies have also�raised the most money - about $770 million)�plus�the New York/northern New Jersey region is also home to�eight. San Diego�came in third with six IPOs followed by San Francisco with five while only five of the 45 biotech IPOs�came from outside the�US (Three from Israel and two from Europe). However, the above figures may change as by his account, there are 15 additional biotech companies in line to go public. More Biotechs Set IPO Terms. The small cap biotech space is about to be joined by a few new additions as a couple of biotechs file to go public�over the past�week or so: Relypsa, which is d

Top 10 Gas Utility Companies To Watch For 2015: WisdomTree Europe SmallCap Dividend Fund (DFE)

WisdomTree Europe SmallCap Dividend Fund is a non-diversified fund. It seeks investment results that closely correspond to the price and yield performance, before fees and expenses, of the WisdomTree Europe SmallCap Dividend Index.

The WisdomTree Europe SmallCap Dividend Index is a fundamentally weighted index that measures the performance of the small-capitalization segment of the European dividend-paying market. The Index is comprised of the companies that compose the bottom 25% of the market capitalization of the WisdomTree Europe Dividend Index.

Advisors' Opinion:

• [By Matthew McCall]

  The European equity rebound continues and within the region the small cap stocks have been quietly performing very well. The WisdomTree Europe Small Cap Dividend ETF (NYSE: DFE) focuses on small cap stocks that pay high dividends.

Top 10 Gas Utility Companies To Watch For 2015: Hyperion Therapeutics Inc (HPTX)

Hyperion Therapeutics, Inc. (Hyperion), incorporated in November 2006, is a development-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology. The Company develops Ravicti (glycerol phenylbutyrate) to treat the prevalent urea cycle disorders (UCD) and hepatic encephalopathy (HE). The Company has completed two Phase II trials and one pivotal Phase III trial of Ravicti. The Company�� HE clinical program consists of two trials, which have enrolled patients with cirrhosis. On December 23, 2011, the Company submitted a new drug application (NDA) for Ravicti for the chronic management of UCD in patients aged six years and above based on data from its pivotal Phase III trial in adult patients and the results of two Phase II trials, one in adults and one in pediatric patients aged 6 through 17 years. In June 2013, Hyperion Therapeutics Inc announced that the completion of its acquisition of BUPHENYL (sodium phenylbutyrate) Tablets and Powder from Ucyclyd Pharma Inc., a subsidiary of Valeant Pharmaceuticals International, Inc.

In June 2011, the Company completed a 24-month carcinogenicity study of Ravicti in rats. On March 22, 2012, pursuant to an asset purchase agreement (purchase agreement) with Ucyclyd Pharma, Inc., a wholly owned subsidiary of Medicis Pharmaceutical Corporation, the Company purchased all of the worldwide rights to Ravicti. The Company also has an option to acquire all of Ucyclyd�� worldwide rights in BUPHENYL and AMMONUL (sodium phenylacetate and sodium benzoate) injection.

The Company conducted a pivotal Phase III trial of Ravicti in adult patients 18 years of age or older with UCD. The Company completed a second Phase II trial at five centers in North America in UCD patients aged 6 through 17 years. This trial includes two phases: a two-week, open-label, safety, tolerability, pharmacokinetic characteristics and ammonia control of Ravicti. The Co! mpany enrolled 77 adult and pediatric UCD patients in its two 12-month open-label safety studies, 69 of whom completed the studies. The Company conducted nonclinical genotoxicity and carcinogenicity studies to assess the tumorigenic potential of Ravicti in animals and to assess the relevant risk in humans. The Company is conducting a Phase II multi-center study of patients with cirrhosis and episodic HE.

Advisors' Opinion:

• [By Jesse Solomon]

  NPS Pharmaceuticals (NPSP), for example, created a drug for treating short bowel syndrome. And Hyperion Therapeutics (HPTX) is developing a drug for hepatic encephalopathy, a decline of brain function that according to the National Institute of Health occurs when the liver is no longer able to remove toxins from the blood. Those stocks are up 20% and 40%, respectively, this year.

• [By Sean Williams]

  What: Shares of Hyperion Therapeutics (NASDAQ: HPTX  ) , a biopharmaceutical company focused on treatments for orphan diseases and hepatology, rose as much as 10% after receiving orphan drug exclusivity status for Ravicti from the Food and Drug Administration, and exercising an option to acquire two additional urea cycle drugs from Valeant Pharmaceuticals (NYSE: VRX  ) .